Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

pembrolizumab 603 Cyclophosphamide 545 Magnetic Resonance Spectroscopy 527 Radiotherapy 513 Specimen Handling 505 Nivolumab 411 Cisplatin 381 Carboplatin 369 Biopsy 305 Blood Specimen Collection 304 Radiosurgery 290 Paclitaxel 281 Gemcitabine 271 Surveys and Questionnaires 269 Standard of Care 267 fludarabine 263 Drug Therapy 263 Dexamethasone 263 Bevacizumab 252 venetoclax 251 Oxaliplatin 209 Capecitabine 199 Rituximab 198 Radiation 191 Ipilimumab 188 Fluorouracil 188 durvalumab 185 Doxorubicin 178 Etoposide 177 atezolizumab 172

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Megestrol × 1 year × Clear all

NCT00420563 2026-03-16

PAL-ANGI

Centre Oscar Lambret

Phase 2 Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡